301 BINNEY STREET, CAMBRIDGE, MA
Merger Agreement Announcement Conference Call, Investor Presentation
Announces Progress Toward CYC-126 Phase 2 Proof-of-Concept Study with FDA Feedback and Formation of Clinical Advisory Board
Investor Presentation
Other Events
News
Material Contracts
News, Material Contracts
Q1
Amended Annual Report
Q3
Q2
FY 2024
S-4
Prospectus Filed Pursuant to Rule 425
Effectiveness Notice
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities to be Offered to Employees
Definitive Proxy Statement
Additional Proxy Materials
Definitive Merger Proxy Statement
Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Amended Schedule 13G - Ownership Report
Correspondence
Submission Upload